NeoPharm, Inc. - Common Stock

LAKE BLUFF , Ill . - - ( BUSINESS WIRE ) - - NeoPharm , Inc . ( NASDAQ : NEOL ) , today announced that , on September 2 , 2008 , the Company received a letter from the NASDAQ Listing Qualifications ...

marketing of the Company's drug compounds including , but not limited to , the Company's ability to fund and pursue additional testing of Cintredekin Besudotox and its NeoLipid drug product candidates ...

( RTTNews ) - NeoPharm , Inc . ( NEOL : News , Chart , Quote ) reported a second - quarter net loss of $2.1 million , or $0.07 per share , as compared to a net loss of $3.6 million , or $0.13 ...

x and its NeoLipid drug product candidates , uncertainty regarding the outcomes of ongoing or potential clinical studies , the Company's financial guidance and projections , the Company's ability ...

LONG BEACH ( Mffais . com ) - Ubs Ag added additional 2,776 ( 177.04 % ) shares of Neopharm Inc ( NEOL ) , bringing their current holdings to 4,344 shares as shown by filings made public on 2008 ...